Like many chemotherapy agents, anthracenediones can cause a range of side effects. Common adverse effects include nausea, vomiting, myelosuppression (a decrease in bone marrow activity), and cardiotoxicity. The risk of cardiac damage is a significant concern, especially with cumulative doses. Patients undergoing treatment with anthracenediones require careful monitoring to manage these side effects effectively.
